Healthy Extracts Secures $555,556 Convertible Note From Hinterland Partners
Healthy Extracts (HYEX) secured a $555,556 convertible note from Hinterland Partners, receiving $459,500 net. The 30-month note has 13% annual interest, monthly revenue-based payments starting March 2027, and a $2.00 conversion price. The company pledged its assets as collateral, with the agreement terminating upon a Nasdaq, NYSE, or NYSE American listing.
How this was made

The 30-second read
Why it matters
Traders should assess HYEX’s credit risk (secured collateral), equity dilution risk (conversion at $2.00/share with adjustments), and cash-flow burden (monthly payments based on prior-month gross revenue starting March 2027).
Market read
A new secured convertible financing with revenue-linked payments and a fixed conversion price is a direct catalyst for HYEX’s balance-sheet and dilution outlook.
What to watch
Key sensitivities are the actual gross revenue base used for the 12.5% monthly payment and how quickly conversion becomes likely relative to the company’s path to a Nasdaq/NYSE listing trigger.
Background
The filing describes a secured convertible promissory note and a related security agreement pledging substantially all assets, with termination tied to an initial listing on major US exchanges.
Ticker impact
Healthy Extracts issued a $555,556 secured convertible note with 13% interest and monthly revenue-linked payments, pledging substantially all assets.
Likely downside pressure as investors price higher leverage and dilution risk, partially offset by cash runway from the note.
The article discloses the note size, interest rate, revenue-linked payment structure starting March 2027, conversion price, and substantially-all-assets collateral, all of which affect credit and equity risk.
Market effects
Adds to the broader pattern of small-cap biotech/healthcare issuers using secured convertibles with revenue-linked payments, which can weigh on peer credit spreads and equity risk appetite.
Limited spillover beyond US micro/small-cap financing sentiment.
Minimal, as the disclosure is company-specific and not tied to global macro or cross-border markets.
Counterpoint
The secured convertible provides defined financing and may reduce immediate liquidity stress, which can stabilize the stock if investors focus on runway rather than dilution.
Key entities
- issuerHealthy Extracts Inc.
Company that issued the secured convertible note and pledged substantially all assets to secure it.
- counterpartyHinterland Partners
Investor/holder providing the $555,556 secured convertible note financing.
